|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D27.0 |
Benign neoplasm of right ovary
Diagnosis Valid for Female Patient Only
|
D270 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 41.29%
|
25.25%
|
12.19%
|
8.06%
|
5.09%
|
3.04%
|
1.48%
|
0.82%
|
0.63%
|
0.48%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D27.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
1,925
|
3,749
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,835
|
8,686
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,692
|
48,334
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,459
|
10,592
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,437
|
2,135
|
|
58661
|
LAPAROSCOPY REMOVE ADNEXA |
1,377
|
1,377
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
1,361
|
7,247
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,361
|
4,405
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,342
|
1,634
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
966
|
1,976
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
936
|
1,673
|
|
86900
|
BLOOD TYPING SEROLOGIC ABO |
923
|
943
|
|
86901
|
BLOOD TYPING SEROLOGIC RH(D) |
921
|
937
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
912
|
3,638
|
|
J1170
|
HYDROMORPHONE INJECTION |
900
|
1,420
|
|
J7120
|
RINGERS LACTATE INFUSION |
900
|
1,414
|
|
86850
|
RBC ANTIBODY SCREEN |
825
|
827
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
816
|
828
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
814
|
848
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
706
|
777
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D27.0 related to the following DRG Codes:
742-743
760-761
|
